System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Christine Bodemer is an expert in Dermatology at Hôpital Necker-Enfants Malades (France). As of October 2026, ScienceLeadR ranks Christine Bodemer in the top 1% of experts worldwide for Skin Abnormalities, Ichthyosis and Keratosis. Christine Bodemer has authored 770 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 7 of them ongoing. SLR score: 2,680 (community average: 125). How the SLR is computed.

LeadR Profile

Christine Bodemer Hôpital Necker-Enfants Malades France
2 680 ScienceLeadR Reputation 2680

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Pediatrics - Immunology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1989 - 2026
Source: PubMed

Imagine Institute for Genetic Diseases

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 770

Citations

Citations: 25 791 1st author: 43 Last author: 177 Unique author: 14

Main journals

Ann Dermatol Venereol 215
Br J Dermatol 73
J Eur Acad Dermatol Venereol 37
J Am Acad Dermatol 23
Orphanet J Rare Dis 21

Best Journals

Nat Med 2
Lancet 1
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Correction: Effectiveness and Safety of IL‑17A Inhibitors in Pediatric Psoriasis: A Real‑World, Multicenter, International Study.
PMID 42870136 — safety, pharmaceutical preparations, psoriasis		Paediatr Drugs20260
Clinical findings of women with X-linked hypohidrotic ectodermal dysplasia.
PMID 42803177 — sexually transmitted diseases, skin diseases, breast feeding, ectodermal dysplasia 1, anhidrotic, ectodermal dysplasia, genes, x-linked		J Eur Acad Dermatol Venereol20260
Epidermal Necrolysis in Children: Clinical Characteristics and Prognosis: An International Retrospective Multicenter Study (ChildTEN Study).
PMID 42791607 — syphilis, dermatology, prognosis, child		Br J Dermatol20260
An isogenic hiPSC-derived keratinocyte model reveals CXCL10/CXCL11 inflammatory dysregulation in epidermolysis bullosa simplex.
PMID 42698624 — cells, epidermolysis bullosa simplex, phenotype, epidermolysis bullosa, induced pluripotent stem cells, keratinocytes, therapeutics, keratins		Front Cell Dev Biol20260
Germline EZH2 mutation cooperates with somatic KIT D816V to drive early pediatric advanced systemic mastocytosis.
PMID 42610275 — mastocytosis, systemic, mastocytosis, mutation		Haematologica20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 1 Study Director: 2

By phase:

N/A 8
Phase 2 6
Phase 3 2
Phase 1/Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 8
Recruiting 7
Unknown 2
Not yet recruiting 1

By type:

Interventional 13
Observational 5

By Monocentric/Multicentric:

monocentric 6
multicentric2to4 1
multicentric5to9 6
multicentricup10 5

Main Topics

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Long Term Safety and Efficacy evaluation of amlitelimab in participants of previous amlitelimab moderate to severe atopic dermatitis clinical trials
2023-506548-18-00 — safety, dermatitis, dermatitis, atopic		Phase 2/Phase 3Not yet recruiting2022
EBUL0 A 20 Week Multicentre Open Study Assessing the Efficacy and Safety of Apremilast in Patients 6 years of age with Epidermolysis bullosa simplex generalized
2023-508794-83-00 — safety, epidermolysis bullosa simplex, epidermolysis bullosa		Phase 2Recruiting2025
Study of Skin and Gut Microbiome in a Skin Condition Involving Skin Barrier Impairment and Allergic Symptoms Netherton Syndrome
NCT07280091 — netherton syndrome, cytokines, skin, life style, mycobiome, blood, blood specimen collection, data collection, signs and symptoms, therapeutics, gastrointestinal microbiome, demography, skin microbiome		N/ARecruiting2026
Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project
NCT06549218 — digital technology, whole genome sequencing, infant, newborn, rare diseases, neonatal screening, genome, signs and symptoms, diagnosis, genetic diseases, inborn		N/ARecruiting2024
A 20 Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
NCT06509984 — safety, epidermolysis bullosa simplex, epidermolysis bullosa, therapeutics, child		Phase 2Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS